Cigna Group (CI) shareholders
Close on Nov 12, 2026Market cap $78.29BP/E 13.1Yield 2.04%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 19,941,446 | 7.40% | 13G (passive) amendment | Mar 31, 2025 |
| Vanguard Capital Management | 19,814,433 | 7.51% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CI | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 23,438,250 | 8.87% | $6.46B | +840,098 | 0.10% |
| Vanguard Capital Management LLC | 17,276,296 | 6.54% | $4.76B | +154,227 | 0.10% |
| State Street Corp | 12,682,259 | 4.80% | $3.50B | +399,118 | 0.10% |
| Dodge & Cox | 12,173,875 | 4.61% | $3.36B | +618,088 | 1.76% |
| Massachusetts Financial Services Co /Ma/ | 10,443,691 | 3.95% | $2.90B | −1,151,491 | 0.92% |
| Sanders Capital, LLC | 10,144,617 | 3.84% | $2.80B | −145,765 | 2.80% |
| FMR LLC | 8,018,189 | 3.03% | $2.21B | −2,939,083 | 0.10% |
| Geode Capital Management, LLC | 6,268,347 | 2.37% | $1.72B | +68,005 | 0.09% |
| Vanguard Portfolio Management LLC | 6,228,614 | 2.36% | $1.72B | +65,176 | 0.08% |
| GQG Partners LLC | 5,908,707 | 2.24% | $1.63B | −93,741 | 3.03% |
| JPMorgan Chase & Co | 5,194,363 | 1.97% | $1.45B | −611,276 | 0.08% |
| Morgan Stanley | 3,690,812 | 1.40% | $1.02B | +258,009 | 0.05% |
| Norges Bank | 3,562,699 | 1.35% | $982.16M | New | 0.10% |
| Bank Of America Corp /De/ | 3,002,366 | 1.14% | $827.69M | −179,717 | 0.05% |
| Arrowstreet Capital, Limited Partnership | 2,849,302 | 1.08% | $785.50M | −10,987 | 0.35% |
| Northern Trust Corp | 2,730,687 | 1.03% | $752.80M | +28,086 | 0.09% |
| Ameriprise Financial Inc | 2,608,447 | 0.99% | $719.18M | −174,792 | 0.15% |
| Grantham, Mayo, Van Otterloo & Co. LLC | 2,577,075 | 0.98% | $710.45M | −21,143 | 1.60% |
| Dimensional Fund Advisors LP | 2,512,025 | 0.95% | $692.58M | +85,807 | 0.13% |
| Invesco Ltd. | 2,403,612 | 0.91% | $662.63M | −89,762 | 0.05% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1,689 | 238M | 89.9% | 162 / 674 | 575 / 101 | 19M | 17M |
| Q1 2026 | 1,658 | 235M | 89.0% | 155 / 671 | 557 / 119 | 44M | 18M |
| Q4 2025 | 1,650 | 237M | 89.5% | 200 / 561 | 636 / 132 | 24M | 27M |
| Q3 2025 | 1,611 | 240M | 90.9% | 116 / 577 | 640 / 210 | 21M | 18M |
| Q2 2025 | 1,729 | 237M | 89.6% | 169 / 651 | 592 / 105 | 16M | 20M |
| Q1 2025 | 1,685 | 240M | 91.0% | 195 / 580 | 626 / 131 | 13M | 13M |
| Q4 2024 | 1,639 | 244M | 92.3% | 190 / 534 | 658 / 213 | 17M | 18M |
| Q3 2024 | 1,697 | 246M | 93.2% | 143 / 621 | 604 / 87 | 34M | 11M |
| Q2 2024 | 1,657 | 248M | 93.7% | 143 / 617 | 561 / 120 | 12M | 31M |
| Q1 2024 | 1,655 | 268M | 100.0% | 185 / 546 | 620 / 124 | 20M | 16M |
| Q4 2023 | 1,619 | 267M | 100.0% | 238 / 512 | 598 / 86 | 27M | 16M |
| Q3 2023 | 1,486 | 256M | 96.8% | 120 / 504 | 567 / 95 | 13M | 15M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
986 funds held CI in Q2 2026, 42% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of CI | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 8,398,680 | 3.18% | $2.32B | 0.10% | Jun 30, 2026 |
| Dodge & Cox Stock Fund | 7,985,072 | 3.02% | $2.20B | 1.86% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 6,854,355 | 2.59% | $1.89B | 0.11% | Jun 30, 2026 |
| MFS Value Fund | 5,165,954 | 1.96% | $1.43B | 2.80% | May 31, 2026 |
| iShares Core S&P 500 ETF | 3,637,728 | 1.38% | $1.00B | 0.11% | Jun 30, 2026 |
| Fidelity 500 Index Fund | 3,371,552 | 1.28% | $935.27M | 0.11% | May 31, 2026 |
| Vanguard Windsor Ii Fund | 2,866,486 | 1.08% | $799.89M | 1.20% | Jul 31, 2026 |
| Vanguard Value Index Fund | 2,518,810 | 0.95% | $694.39M | 0.27% | Jun 30, 2026 |
| State Street(R) Health Care Select Sector SPDR(R) ETF | 1,868,792 | 0.71% | $515.19M | 1.27% | Jun 30, 2026 |
| Vanguard Institutional Index Fund | 1,436,072 | 0.54% | $395.90M | 0.11% | Jun 30, 2026 |
| Strategic Advisers Fidelity U.S. Total Stock Fund | 1,104,902 | 0.42% | $306.50M | 0.12% | May 31, 2026 |
| Vanguard High Dividend Yield Index Fund | 1,051,091 | 0.40% | $293.31M | 0.30% | Jul 31, 2026 |
| JPMorgan Equity Income Fund | 976,908 | 0.37% | $269.31M | 0.62% | Jun 30, 2026 |
| American Balanced Fund | 870,000 | 0.33% | $239.84M | 0.08% | Jun 30, 2026 |
| Vanguard Health Care Index Fund | 802,292 | 0.30% | $222.56M | 1.17% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| David Cordani | Chairman & CEO, Director | 658,302 | 0.25% | May 14, 2026 |
| Everett Neville | See Remarks | 5,053 | 0.00% | Sep 8, 2026 |
| Brian C. Evanko | See Remarks | 67,564 | 0.03% | Sep 3, 2026 |
| Bryan Holgerson | See Remarks | 7,693 | 0.00% | Aug 20, 2026 |
| Nicole S. Jones | See Remarks | 27,331 | 0.01% | Aug 20, 2026 |
| Adam Kautzner | See Remarks | 13,533 | 0.01% | Jul 9, 2026 |
| Matthew Perlberg | See Remarks | 9,345 | 0.00% | Jul 9, 2026 |
| Jason D. Sadler | See Remarks | 34,705 | 0.01% | Jul 9, 2026 |
| Paul A. Sanford | See Remarks | 4,335 | 0.00% | Jul 9, 2026 |
| Jamie G. Kates | Chief Accounting Officer | 2,368 | 0.00% | Jun 16, 2026 |
| Durga Prasad Koka | EVP, Global CIO | 6,552 | 0.00% | Jun 3, 2026 |
| Andrea L. Nelson | EVP, General Counsl & Corp Sec | 3,912 | 0.00% | Apr 3, 2026 |
| Ann M. Dennison | EVP, CFO | 8,154 | 0.00% | Mar 3, 2026 |
| David J. Brailer | EVP & Chief Health Officer | 17,525 | 0.01% | Sep 3, 2025 |
| Noelle K. Eder | See Remarks | 13,590 | 0.01% | Mar 11, 2025 |
| Eric P. Palmer | See Remarks | 75,295 | 0.03% | Mar 4, 2025 |
| George Kurian | Director | 4,560 | 0.00% | Sep 2, 2026 |
| Eric C. Wiseman | Director | 23,940 | 0.01% | Apr 24, 2026 |
| Eric J. Foss | Director | 36,696 | 0.01% | Apr 24, 2026 |
| Donna F. Zarcone | Director | 27,517 | 0.01% | Apr 24, 2026 |
| Neesha Hathi | Director | 4,151 | 0.00% | Apr 24, 2026 |
| Michael J. Hennigan | Director | 1,350 | 0.00% | Apr 24, 2026 |
| Mark B. McClellan | Director | 6,891 | 0.00% | Apr 24, 2026 |
| Kimberly A. Ross | Director | 5,294 | 0.00% | Apr 24, 2026 |
| Kathleen M. Mazzarella | Director | 6,891 | 0.00% | Apr 24, 2026 |
| Philip Ozuah | Director | 2,583 | 0.00% | Apr 24, 2026 |
| Elder Granger | Director | 6,109 | 0.00% | Apr 25, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Everett Neville See Remarks | Sep 3, 2026 | Sale(10b5-1 plan) | −617 | $284.05 | $175.26K | 5,053 |
| Brian C. Evanko See Remarks | Sep 1, 2026 | Award | +3,113 | – | – | 41,030 |
| Nicole S. Jones See Remarks | Aug 18, 2026 | Sale(10b5-1 plan) | −2,677 | $279.61 | $748.52K | 25,880 |
| Nicole S. Jones See Remarks | Aug 5, 2026 | Option exercise | +1,301 | $192.02 | $249.82K | 28,557 |
| Nicole S. Jones See Remarks | Aug 4, 2026 | Option exercise | +14,045 | $192.02 | $2.70M | 46,692 |
| Nicole S. Jones See Remarks | Aug 4, 2026 | Sale(10b5-1 plan) | −19,436 | $276.27 | $5.37M | 27,256 |
| Jamie G. Kates Chief Accounting Officer | Jun 12, 2026 | Sale | −899 | $298.61 | $268.45K | 2,368 |
| Jamie G. Kates Chief Accounting Officer | Jun 12, 2026 | Option exercise | +899 | $152.89 | $137.45K | 3,267 |
| Durga Prasad Koka EVP, Global CIO | Jun 1, 2026 | Tax withholding | −729 | $275.53 | $200.86K | 6,552 |
| David Cordani Chairman & CEO, Director | May 13, 2026 | Option exercise | +7,971 | $197.35 | $1.57M | 57,766 |
| David Cordani Chairman & CEO, Director | May 13, 2026 | Option exercise | +15,458 | $149.14 | $2.31M | 49,795 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Sale(10b5-1 plan) | −2,231 | $298.53 | $666.02K | 34,337 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Sale(10b5-1 plan) | −15,319 | $298.24 | $4.57M | 36,568 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Sale(10b5-1 plan) | −2,017 | $296.84 | $598.73K | 51,887 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Sale(10b5-1 plan) | −34,641 | $295.98 | $10.25M | 53,904 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Sale(10b5-1 plan) | −38,487 | $294.98 | $11.35M | 88,545 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Sale(10b5-1 plan) | −2,142 | $293.92 | $629.58K | 127,032 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Sale(10b5-1 plan) | −7,861 | $292.88 | $2.30M | 129,174 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Sale(10b5-1 plan) | −12,315 | $291.95 | $3.60M | 137,035 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Sale(10b5-1 plan) | −13,732 | $291.01 | $4.00M | 149,350 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Sale(10b5-1 plan) | −41,099 | $290.00 | $11.92M | 163,082 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Sale(10b5-1 plan) | −13,839 | $288.85 | $4.00M | 204,181 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Sale(10b5-1 plan) | −14,292 | $287.96 | $4.12M | 218,020 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Sale(10b5-1 plan) | −3,903 | $286.83 | $1.12M | 232,312 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Option exercise | +85,519 | $197.35 | $16.88M | 236,215 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Option exercise | +103,595 | $149.14 | $15.45M | 150,696 |
| Michael J. Hennigan Director | Apr 22, 2026 | Award | +782 | – | – | 1,350 |
| Neesha Hathi Director | Apr 22, 2026 | Award | +782 | – | – | 4,151 |
| Eric J. Foss Director | Apr 22, 2026 | Award | +782 | – | – | 36,696 |
| Mark B. McClellan Director | Apr 22, 2026 | Award | +782 | – | – | 6,891 |
| George Kurian Director | Apr 22, 2026 | Award | +782 | – | – | 4,560 |
| Philip Ozuah Director | Apr 22, 2026 | Award | +782 | – | – | 2,583 |
| Kathleen M. Mazzarella Director | Apr 22, 2026 | Award | +782 | – | – | 6,891 |
| Kimberly A. Ross Director | Apr 22, 2026 | Award | +782 | – | – | 5,294 |
| Donna F. Zarcone Director | Apr 22, 2026 | Award | +782 | – | – | 27,517 |
| Eric C. Wiseman Director | Apr 22, 2026 | Award | +782 | – | – | 23,940 |
| Everett Neville See Remarks | Mar 2, 2026 | Sale(10b5-1 plan) | −1,719 | $288.91 | $496.64K | 5,670 |
| Nicole S. Jones See Remarks | Mar 2, 2026 | Sale(10b5-1 plan) | −2,307 | $288.91 | $666.52K | 32,647 |
| Brian C. Evanko See Remarks | Feb 27, 2026 | Tax withholding | −2,979 | $287.55 | $856.61K | 39,705 |
| Brian C. Evanko See Remarks | Feb 27, 2026 | Tax withholding | −1,788 | $287.55 | $514.14K | 37,917 |
| Brian C. Evanko See Remarks | Feb 27, 2026 | Award | +6,428 | – | – | 32,897 |
| Brian C. Evanko See Remarks | Feb 27, 2026 | Award | +9,787 | – | – | 42,684 |
| Jamie G. Kates Chief Accounting Officer | Feb 27, 2026 | Tax withholding | −61 | $287.55 | $17.54K | 2,368 |
| Jamie G. Kates Chief Accounting Officer | Feb 27, 2026 | Award | +205 | – | – | 1,891 |
| Jamie G. Kates Chief Accounting Officer | Feb 27, 2026 | Award | +609 | – | – | 2,500 |
| Jamie G. Kates Chief Accounting Officer | Feb 27, 2026 | Tax withholding | −71 | $287.55 | $20.42K | 2,429 |
| Ann M. Dennison EVP, CFO | Feb 27, 2026 | Award | +5,234 | – | – | 8,154 |
| Ann M. Dennison EVP, CFO | Feb 27, 2026 | Tax withholding | −409 | $287.55 | $117.61K | 7,745 |
| Durga Prasad Koka EVP, Global CIO | Feb 27, 2026 | Tax withholding | −122 | $287.55 | $35.08K | 7,379 |
| Durga Prasad Koka EVP, Global CIO | Feb 27, 2026 | Award | +2,678 | – | – | 7,501 |
| Durga Prasad Koka EVP, Global CIO | Feb 27, 2026 | Tax withholding | −98 | $287.55 | $28.18K | 7,281 |
| Durga Prasad Koka EVP, Global CIO | Feb 27, 2026 | Award | +499 | – | – | 4,823 |
| David Cordani Chairman & CEO, Director | Feb 27, 2026 | Award | +17,389 | – | – | 62,533 |
| David Cordani Chairman & CEO, Director | Feb 27, 2026 | Award | +23,788 | – | – | 45,144 |
| David Cordani Chairman & CEO, Director | Feb 27, 2026 | Tax withholding | −11,024 | $287.55 | $3.17M | 51,509 |
| David Cordani Chairman & CEO, Director | Feb 27, 2026 | Tax withholding | −4,408 | $287.55 | $1.27M | 47,101 |
| Everett Neville See Remarks | Feb 27, 2026 | Tax withholding | −517 | $287.55 | $148.66K | 7,389 |
| Everett Neville See Remarks | Feb 27, 2026 | Award | +2,602 | – | – | 6,111 |
| Everett Neville See Remarks | Feb 27, 2026 | Award | +2,678 | – | – | 8,789 |
| Everett Neville See Remarks | Feb 27, 2026 | Tax withholding | −883 | $287.55 | $253.91K | 7,906 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Cigna's stock actually held short. Settlement fails (shares not delivered on time) peaked at 5,850 shares on Sep 25, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Everett Neville Officer | Sep 3, 2026 | 617 | $175.26K | Sep 3, 2026 | Restricted Stock Vesting |
| Nicole S. Jones Officer | Aug 18, 2026 | 2,677 | $748.42K | Aug 18, 2026 | Stock Option Exercise |
| Nicole S. Jones Officer | Aug 4, 2026 | 19,436 | $5.37M | Aug 4, 2026 | Restricted Stock Vesting |
| Jamie G. Kates Officer | Jun 12, 2026 | 899 | $268.45K | Jun 12, 2026 | Stock Option Exercise |
| David Cordani Officer, Director | May 12, 2026 | 201,878 | $59.11M | May 12, 2026 | Restricted Stock Vesting |
| Nicole S. Jones Officer | Mar 2, 2026 | 2,307 | $666.52K | Mar 2, 2026 | Restricted Stock Vesting |
| Everett Neville Officer | Mar 2, 2026 | 1,719 | $496.64K | Mar 2, 2026 | Restricted Stock Vesting |
| Elder Granger Former Director | Feb 6, 2026 | 6,109 | $1.79M | Feb 6, 2026 | Restricted Stock Vesting |
| Brian C. Evanko Officer | Oct 3, 2025 | 5,368 | $1.61M | Oct 3, 2025 | Option Granted 03/01/2016 |
| Nicole S. Jones Officer | Aug 15, 2025 | 28,526 | $8.56M | Aug 15, 2025 | Restricted Stock Vesting |
| Noelle K. Eder Former Officer | Aug 12, 2025 | 35,711 | $9.82M | Aug 12, 2025 | Options Granted - 02/24/2021 |
| Eric P. Palmer Former Officer | May 9, 2025 | 610 | $204.40K | May 9, 2025 | Option Granted - 02/24/2021 |
| Eric P. Palmer Former Officer | May 8, 2025 | 14,985 | $5.03M | May 8, 2025 | Option Granted - 02/24/2021 |
| Eric P. Palmer Former Officer | May 7, 2025 | 87,171 | $29.20M | May 7, 2025 | Option Granted - 02/27/2019 |
| Eric P. Palmer Former Officer | May 6, 2025 | 35,977 | $12.04M | May 6, 2025 | Option Granted 02/28/2018 |
See a number that looks wrong?